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218 L. Egger et al. / Food Research International 88 (2016) 217–225degree of consistency in protein hydrolysiswas investigated. Analysis of the hydrolyzed proteins, after the gastric
and intestinal phases, showed that caseins were mainly hydrolyzed during the gastric phase, whereas β-
lactoglobulin was, as previously shown, resistant to pepsin. Moreover, generation of free amino acids occurred
mainly during the intestinal phase.
The study also showed that a few critical steps were responsible for the remaining inter-laboratory variability.
The largest deviations arose from the determination of pepsin activity. Therefore, this step was further clarified,
harmonized, and implemented in a third inter-laboratory study.
The present work gives an overview of all three inter-laboratory studies, showing that the IVD INFOGESTmethod
has led to an increased consistency that enables a better comparability of in vitro digestion studies in the future.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
In vitro digestion
Dairy proteins
Peptides
Mass spectrometry
Inter-laboratory trial
Harmonized IVD protocol1. Introduction
One major aim of the COST Action INFOGEST FA1005 INFOGEST
(http://www.cost-INFOGEST.eu/) was the elaboration and harmoniza-
tion of in vitro protocols simulating human digestion. A basic static
model was developed and published in 2014 (Minekus et al., 2014).
Many different models have previously been described (Hur, Lim,
Decker, & McClements, 2011; Kopf-Bolanz et al., 2012; McClements &
Li, 2010; Picariello et al., 2010; Versantvoort, Oomen, Van de Kamp,
Rompelberg, & Sips, 2005; Wickham, Faulks, & Mills, 2009). In this con-
text, specific aims of the INFOGEST network were i) to find harmonized
digestion conditions, ii) to develop a staticmodel thatwas easy to set up
and apply for a large research community, and iii) to be able to compare
study results. The parameters proposed by this method were discussed
among experts in the field and were chosen based on previously pub-
lished in vivo values. The harmonized method comprises three steps,
namely an oral, gastric, and intestinal phase, similar to earlier published
models. However, in the past, a major source of discrepancy of results
among laboratories, evenwhen applying the samemethod, was the dif-
ferences in digestive enzyme activities used for IVD. In most cases, di-
gestive enzymes were added based on weight or non-standardized
activity units. To overcome these problems, the new harmonizedmeth-
od proposes a standardized assay for activity determination for each
added enzyme and therefore is expected to improve the comparability
of experimental results between laboratories.
In this study, the increase in harmonization of IVD results between
laboratories of the INFOGEST communitywas investigated. For that pur-
pose, three rounds of inter-laboratory studies were performed applying
IVD to skim milk powder (SMP). SMP was chosen because it is an easy
to ship, stable, and complex food matrix. For the first study, the partici-
pants digested the SMP with their previously used in-house IVD
protocols, and the two following studies were performed with the har-
monized method. All three studies were analyzed with the same
methods, focusing on protein hydrolysis.Whole proteinswere analyzed
by SDS-PAGE, peptides by mass spectrometry, and free amino acids by
HPLC. In the course of the inter-laboratory trials, pepsin activity was
identified as the critical factor in the gastric phase, causing variabilities
in protein hydrolysis during this step. Pepsin activity is highly suscepti-
ble to pH fluctuations (Piper & Fenton, 1965). The determination of
pepsin activity with a classic enzymatic assay adapted from Anson
(Anson, 1938; Anson & Mirsky, 1932) was therefore investigated to
reduce the variability in the gastric hydrolysis.2. Materials and methods
2.1. Chemicals and reagents
SMP (Fonterra, NZ, low-heat organic, protein 42.34%, fat 0.89%,
lactose 49.8% (w/w)) was shipped to the INFOGEST members. All
chemicals and enzymes were from Sigma Aldrich. Three different
pepsins were used: P1, Sigma P6887; P2, Sigma P7012; and P3, Sigma
P7000. Enzymes and bile extracts used for IVD were of porcine origin.2.2. Inter-laboratory trials
In total, three inter-laboratory IVD trials were performed, each with
SMP as food matrix. The participating laboratories were different be-
tween the inter-laboratory trials, therefore the numbering refers only
to the corresponding trial (Table 1). The powder from one single batch
was shipped to the participating laboratories at ambient temperature.
For the first inter-laboratory trial, the participants digested the SMP ac-
cording to their in-house IVD method using enzymes from different
sources. For the second and third trial, the harmonized protocol was
followed. Between the second and third trials, the protocols for the en-
zyme activity measurements and the IVD itself were described in more
detail, and the participants in the third study attended a special training
school during which they learned to apply the enzymatic activity
methods and the harmonized IVD protocol. The same enzyme batches
of pepsin P2 and pancreatin were sent to the participants to reduce
batch-dependent variability.
2.3. In vitro digestion
SMP was digested in vitro using in-house methods (Table 1) or ac-
cording to the harmonized protocol (INFOGEST, 2014; Minekus et al.,
2014). The in-house methods were diverse, and the main known pa-
rameters are summarized in Table 1. For the harmonized protocol, the
SMP (5 mL of a 1/10 dilution of SMP in H2O, w:v) was mixed with
5 mL of simulated saliva without amylase (due to the absence of starch
in SMP), for 2 min and then was mixed with 10 mL of simulated gastric
juice containing pepsin (2000U/mLof digesta, P1, P2 or P3) for 120min.
Subsequently, 20mL of simulated intestinal juice containing pancreatin
(100 U trypsin activity/mL of digesta) and bile (10 mmol/L in the total
digesta) was added and incubated for 120 min. The oral, gastric and in-
testinal steps were performed at 37 °C under constant gentle mixing.
The enzyme activities and the bile concentration were measured ac-
cording to the assays described in the harmonized protocol (Minekus
et al., 2014). The participants were asked to collect samples after the
gastric and the intestinal phases. For the first and second trials, the reac-
tions were stopped by the addition of Pefabloc® (Roche, 1 mM) imme-
diately followed by snap freezing (liquid nitrogen) and freeze-drying of
the samples. For the third trial, the stopping reactions were improved
and consisted of an adjustment of the pH to 7.0 after the gastric phase
and by the addition of Pefabloc® (5 mM) at the end of the intestinal
phase, prior to the snap freezing and freeze-drying of the samples. The
pH shift after the gastric phase is more effective in stopping pepsin
activity and at the same time closer to in vivo conditions found in the
duodenum (Kalantzi et al., 2006). For all three trials, the samples were
shipped to one analyzing laboratory (Agroscope, Switzerland) at ambi-
ent temperature.
2.4. Sample preparation and gel electrophoresis
The freeze dried samples were reconstituted in ammonium bicar-
bonate buffer (100 mM) at 1:2 for gastric and 1:1 for intestinal samples
Table 1
Gastric Phase Intestinal Phase
Trial No. of
partici-pants
Laboratory Short:
30-60 min
Long:
120-180
min
Dynamic Short:
30-60 min
Long:
120-180
min
Dynamic Pancreatin, Enzymes,
Human Duodenal Juice
References
In-house
protocols
1 12 1 x x P (Versantvoort et al., 2005)
2 x x P (Kopf-Bolanz et al., 2012)
3 x x P (Versantvoort et al., 2005)
4 x x P (Kopf-Bolanz et al., 2012)
5 x x E (Dupont et al., 2010)
6 x x x x P (Menard et al., 2014)
7 x x J (Ulleberg et al., 2011)
8 x x x x E (Shani-Levi, Levi-Tal, & Lesmes, 2013)
9 x x P (Vreeburg, van Wezel, Ocana-Calahorro, & Mes, 2012)
10 x x E (Martos, Contreras, Molina, & Lopez-Fandino, 2010)
11 x x P (Alemany et al., 2013)
12 x x P (Kenmogne-Domguia, Meynier, Boulanger, & Genot, 2012;
Kenmogne-Domguia, Meynier, Viau, Llamas, & Genot, 2012)
Harmonized
protocol
2.
and
3.
10 1.1 -1.10 x x P (Minekus et al., 2014)
7 2.1-2.7
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220 L. Egger et al. / Food Research International 88 (2016) 217–225corresponding to the original volume of SMP input. For gel electropho-
resis, equal volumes were mixed with a sample buffer (Tris–HCl
350mM, pH6.8, SDS 10%, DTT 100mM, glycerol 50%) andwere separat-
ed by SDS-PAGE (15% polyacrylamide). A molecular weight marker
(Benchmark™, Invitrogen) and undigested SMP (1:400, mixed with
sample buffer) were included on each gel. Thereafter, the gels were
stained with colloidal Coomassie Blue (Kang, Gho, Suh, & Kang, 2002).2.5. LC–MS peptide identification and length analysis
MS analysis was performed as previously described (Kopf-Bolanz
et al., 2012). Briefly, samples were filtered through Microcon columns
(Ultracel YM-30, Millipore), and the peptides were separated on a
Rheos 2200 HPLC (Flux Instruments, Switzerland) equipped with an
XTerra MS C18 column (3.5 μm, 1.0 mm × 150 mm, Waters). The
HPLC was directly coupled to a linear ion trap mass spectrometer
(LTQ, Thermo Scientific, Switzerland) using an ESI interface. The sam-
ples were measured in multiple overlapping narrow mass windows
spanning an m z−1 between 100 and 1300, and all raw files were
merged for an identification search with Mascot (Matrix Science),
using a database containing the major milk proteins of different origin.
The search engine parameters were set as follows: instrument
configuration ESI-trap, consideration of average masses, peptide charge
1+, 2+, 3+, enzyme: none, variable peptidemodificationswere Gln→
pyro-Glu(N-term Q), oxidation (M), phosphor (S, T), peptide and MS/
MS tolerance 0.8 Da. Peptides from the five major milk proteins (β-ca-
sein, αs1-casein, αs2-casein, κ-casein, β-lactoglobulin) with a minimal
length of five amino acids (AA) were considered. The identification re-
sults were verified manually. For better visualization of peptide abun-
dance, colored peptide patterns were generated by summing up the
number of individual amino acids within the identified peptides from
the above mentioned dairy proteins. The colors are ranging from
green to red, indicating low and high recurrence of specific amino
acids, respectively. Unidentified protein sequences are shown as white
stretches. The colors were normalized to the maximal number of iden-
tifications within the corresponding protein and digestion phase,
e.g. red in αs1-casein can correspond to a different number for red in
β-lactoglobulin.2.6. HPLC analysis
For determination of free amino acids, the freeze dried sampleswere
reconstituted, normalized to SMP input as described for gel electropho-
resis and equal volumes were analyzed by HPLC according to the meth-
od published by Bidlingmeyer and coworkers (Bidlingmeyer, Cohen, &
Tarvin, 1984).2.7. Determination of pepsin activity
Pepsin activity was measured as described in the Supplemental ma-
terial of the harmonized protocol (Minekus et al., 2014). Briefly, hemo-
globin 2% (w/v) served as substrate, pepsin 1mg/mL stock solutionwas
dissolved in NaCl 150 mM at pH 6.5 and several dilutions (5–35 μg/mL)
were preparedwith HCl 10mM just before the activity test. For the test,
500 μL of substrate solution was incubated at 37 °C for 4 min, 100 μL of
enzyme solution was added and after precisely 10min the reaction was
stopped with trichloroacetic acid (TCA, 5%). The samples were centri-
fuged at 6000 g for 30min and the absorbance (280 nm)wasmeasured.
For each sample, a blankwas run in parallel, towhich the corresponding
pepsin solution was added after the TCA. A ΔA280 of 0.001 at pH 2.0 and
37 °C corresponded to 1 U. It was monitored that the activities from
each tested pepsin concentration were the same, to ensure that only
the linear part of the curve was considered.2.8. Spearman correlation
Spearman correlations were calculated for the gastric and intestinal
phase considering the five investigated proteins (β-casein, αs1-casein,
αs2-casein, κ-casein, and β-lactoglobulin) based on the data of the pep-
tide patterns shown in Fig. 2. The number of times an amino acid was
found within an identified peptide was summed up, aligned according
to the amino acid sequence and compared with each other laboratory
within a trial.
2.9. Replication of experiments and statistical analysis
The samples obtained from the participants were analyzed at least
three times by gel electrophoresis, analyzed in triplicate by mass spec-
trometry and in duplicate by HPLC. Representative gels are shown as
well as the average values of the results. The Spearman correlation ma-
trix was calculated with SYSTAT 13 software (SYSTAT, Inc. Richmond,
CA) using the following settings: one set of variables, rank order data
(Spearman).
3. Results and discussion
The COST Action FA1005 INFOGEST (http://www.cost-INFOGEST.eu/)
aimed at the harmonization of IVD methods. The work of one subgroup
(WG 2) was dedicated to the elaboration of a general standardized and
practical static IVD protocol allowing a better comparability of experi-
mental data. The methods were established based on available in vivo
data and published in 2014 (Minekus et al., 2014). Meanwhile, the com-
parability of IVD experiments was studied in three inter-laboratory trials
using SMP and analyzing the hydrolysis of proteins with SDS-PAGE, mass
spectrometry and HPLC. The latter analysis was only performed for the
harmonized protocol, as it detects total free amino acids and the ratios be-
tween SMP substrate and added enzymes were not comparable in the
first trial with in-house IVD protocols.
3.1. Protein hydrolysis during in vitro digestion
Protein hydrolysis was analyzed with Coomassie-stained SDS PAGE
after the gastric and intestinal digestion phases (Fig. 1). To obtain an
equal loading of SMP protein in each lane, the samples were
reconstituted according to their dilution during in vitro digestion. Amo-
lecular weight marker and an undigested SMP control were included.
For the first inter-laboratory trial, the participants were asked to per-
form their in-house IVD protocol, and for the second and third inter-
laboratory trials, the harmonized IVD method (Minekus et al., 2014)
was applied. Bands indicated by arrows are proteins thatwere previous-
ly identified by mass spectrometry (data not shown). In a majority of
the samples from all three trials, i) a band of intact β-lactoglobulin
was present after the gastric phase as well as ii) a doublet band corre-
sponding to pepsin (Fig. 1a, b and c, arrow), and iii) caseinsweremostly
hydrolyzed. α-Lactalbumin (α-la, 15–19 kDa) was visible in the undi-
gested sample (SMP) but was not detected after the gastric phase
(Fig. 1a, b, c). In contrast to that, the protein pattern of the intestinal
phase was more diverse after the first inter-laboratory trial (Fig. 1d),
compared to the two trials performed with the harmonized method
(Fig. 1e, f). Thus for example, in some samples from the first inter-
laboratory trial (5, 6, 11), β-lactoglobulinwas still visible after the intes-
tinal phase. One strong band in the intestinal phase, shown with an
arrow, was identified by mass spectrometry (data not shown) as
α-amylase (Fig. 1d, e, f). The other bands were previously identified as
digestive enzymes originating from pancreatin (data not shown).
The improvement in consistency with the harmonized method was
clearly visible at the protein level compared to the first inter-laboratory
trial (in-house protocols) where discrepancies in the degree of
β-lactoglobulin hydrolysis were clearly visible. In some samples, the
protein was completely hydrolyzed during the gastric phase, while in
Fig. 1. Protein hydrolysis after gastric and intestinal phases of IVD. Representative Coomassie-stained SDS-PAGE gels of the three inter-laboratory trials; upper gels are samples stopped
after the gastric and lower gels after the intestinal phase. The first inter-laboratory trial was performedwith in-house IVD protocols, while for the two other trials, the participants applied
the harmonized protocol (Minekus et al., 2014). The sample numbering refers only to the corresponding participant in the trial. Bands indicated with arrows have been previously iden-
tified asmilk protein (β-lactoglobulin,α-lactalbumin (α-la)) or enzymes present in gastric (pepsin) and pancreatic (amylase) juice (Kopf-Bolanz et al., 2012). SMP is the undigested skim
milk powder; M is a protein marker.
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this discrepancy. It was previously shown that β-lactoglobulin was
resistant to in vitro degradation by pepsin (Mandalari et al., 2009;
Reddy, Kella, & Kinsella, 1988), and this observation was confirmed by
using the harmonized method. The simulated gastric hydrolysis of ca-
seinswas also heterogeneous in the gastric phase in this first trial. Inter-
estingly, this heterogeneity in casein hydrolysis was persistent in some
of the samples of the later trials using the harmonized method. These
discrepancies were most probably due to variable pepsin activities in
the gastric phase. As pepsin is the key enzyme for proteolysis during
the gastric step, its activity during IVD and the enzymatic activity test
was carefully assessed.
3.2. Pepsin activity as key step for gastric protein degradation
To reduce the observed differences in casein hydrolysis during the
gastric phase, the participants in the second trial were asked to indicate
the pepsin source and enzymatic activity they had measured before the
IVD (Fig. 2). In total, three different products (Fig. 2, P1, P2, P3) wereFig. 2.Determination of pepsin activity according to the harmonized protocol. Pepsin activities d
harmonized protocol. Laboratories 2.8 and 2.9 only analyzed pepsin activity but did not participa
Materials andmethods), NaCl: pepsin dissolved in NaCl 150mM, pH 6.5; Tris: pepsin dissolved
shown.used and for all three a high variability in activity was reported. In par-
ticular the sample digestedwith P3 (Fig. 2), forwhich a very low activity
was reported, had very few peptides released during the gastric phase,
as could be observed by peptide analysis (Fig. 2, sample 1.7). Two pos-
sible explanations for the high variability could be advanced. Firstly, to
exclude the possibility that the variability originated from the different
pepsins preparations, the third inter-laboratory trial was performed
using one pepsin from the same batch (Fig. 2, P2), which was shipped
between the participants and analyzed for its activity beforehand. How-
ever, although the laboratories all applied the same protocol ((Minekus
et al., 2014), Supplemental Data) for this determination, the results
were again highly variable. The third inter-laboratory trial was per-
formed with the average pepsin activity determined by nine different
laboratories, excluding two outliers (2976± 591 U/mg). Pepsin activity
is known to be strongly dependent on pH and autolysis occurs in the ab-
sence of substrate (Cornish-Bowden & Knowles, 1969; Galea, Dalrym-
ple, Kuypers, & Blakeley, 2000). Its optimal activity is between pH 2
and pH 4, it is essentially inactive above pH 6, and it is irreversibly
inactivated at higher pH (Piper & Fenton, 1965). Therefore, a secondetermined by the participants in the 2nd and 3rd inter-laboratory trials, both applying the
te to the inter-laboratory trial. P1, P2, and P3 stand for different pepsinproducts (Section 2,
in Tris 10mM, NaCl 150mM, pH 6.5. Average values (Av)with standard deviation (SD) are
Fig. 3. Peptide patterns after gastric and intestinal phases of IVD. (a) Peptide pattern ofαs2-casein of all three inter-laboratory trials; upper block, two trials applying the harmonized pro-
tocol (Harmonized), participants 1.1–7 and 2.1–10, and lower block, with in-house protocols, participating laboratories 1–12. (b) Average peptide patterns of the fivemost abundantmilk
proteins, β-casein, αs1-casein, αs2-casein, κ-casein, and β-lactoglobulin after the gastric (G) and intestinal (I) phases. Averages were calculated for two groups: harmonized protocol
(a) and in-house protocols for IVD (b). The color code is green for low numbers and red for high numbers of detected amino acids. Red color was attributed depending on protein and
digestion phase (gastric: G/intestinal: I) and was normalized to the maximal number of detected amino acids within a identified peptide of the corresponding protein: β-casein (G:
312/I: 127), αs1-casein (G: 92/I: 79), αs2-casein (G: 205/I: 127), κ-casein (G: 47/I: 30), and β-lactoglobulin (G: 29/I: 54).
222 L. Egger et al. / Food Research International 88 (2016) 217–225possibility for the variability in pepsin activity, namely the pH stability
during pepsin activity determination was further investigated. The pH
of the solution used for pepsin dilution (NaCl, 150 mM, pH 6.5) was
measured several times during one day of analysis, and it changed
from 6.02 to 6.46 (data not shown). To improve pH stability, Tris
was added due to its buffering capacity (Tris-(hydroxymethyl)-
aminomethane 10 mM, NaCl 150 mM, pH 6.5). Pepsin was dissolved
in both solutions and the activity was measured in three independent
experiments (Fig. 2, P1). The activity of pepsin in NaCl solution was
slightly higher with a greater variability (Fig. 2, NaCl: 3434 ±
309 U/mg powder) than in the Tris buffer, which indeed reduced the
variability of the measured activity (Fig. 2, Tris: 3057 ± 214 U/mgpowder). These additional tests were performed in one laboratory and
need to be confirmed by a comparison within several laboratories.
Note that the average activity of P2 was higher in the third inter-
laboratory trial, which may possibly be due to batch variabilities.
3.3. Peptide generation during in vitro digestion
Peptide generation during IVD was analyzed by mass spectrometry
for all three inter-laboratory trials. To allow a comparison of the results
among the different laboratories, a color code was introduced that
simultaneously allowed a quantitative evaluation of how many times
an amino acid was identified and also visualized regions within a
223L. Egger et al. / Food Research International 88 (2016) 217–225protein that were more resistant to digestion (Fig. 3a, Supplemental
Data). For each sample from all three trials, after the gastric and intesti-
nal digestion phases, a colored peptide patternwas generated according
to Section 2.5, for the five most abundant milk proteins (β-casein,
αs1-casein, αs2-casein, κ-casein, and β-lactoglobulin). In general, the
peptide patterns obtained with the in-house protocols were different
between laboratories, comprising a high number of peptideswhich cov-
ered nearly thewhole protein sequences (Fig. 3a, in-house 1–12). How-
ever, both trials with the harmonized IVD had a similar inter-laboratory
patternwith a lower number of peptideswhich covered only certain re-
gions of the protein (Fig. 3a, harmonized, 1.1–10 and 2.1–7). The num-
ber of peptides observed in the harmonizedmethod decreased between
the gastric and intestinal phases, indicating the expected progression in
the digestion process. Both observations (protein coverage and number
of peptides) point toward a higher degree of digestion in the harmo-
nized method.
The differences between the in-house protocols and the harmonized
IVD were observed in all investigated proteins in a similar way
(Supplemental Data). These differences are summarized in Fig. 3b,Fig. 4. Spearman correlationmatrices showing the degree of harmonization. Spearman correlat
tocol, separating the gastric from the intestinal phases. Red color indicates good correlation (clo
from the correlation due to various reasons (Section 3.5).which shows for each of the five proteins an average peptide pattern
for (a) the harmonized and (b) the in-house IVD, each time
distinguishing the gastric (G) and the intestinal (I) phases. Several pep-
tide sequences persisted at higher frequency after the intestinal phase
and were consistent in all three trials, indicating that those sequences
were resistant to hydrolysis, possibly because of intrinsic structural
traits. Regions that are in yellow or orange in the average peptide pat-
tern (Fig. 3b) indicate such highly resistant regions, and it would be in-
teresting to investigate whether these regions are sources for bioactive
peptides or allergenic epitopes. However, the goal of this study was to
obtain a measure of the comparability of analytical results between dif-
ferent laboratories.
3.4. Correlation of peptide patterns between in-house and harmonized IVD
The peptide patterns of the different laboratories were aligned, and
each peptide pattern was compared to every other pattern using a
Spearman correlation between laboratories (Fig. 4). The first two corre-
lations compared the results from the first inter-laboratory trial, forions were calculated for the in-house trial and the two trials applying the harmonized pro-
se to 1), and green indicates low correlation (going to 0). Some laboratorieswere excluded
224 L. Egger et al. / Food Research International 88 (2016) 217–225which the participants applied their in-house methods to simulate di-
gestion of SMP, for the gastric and the intestinal phases, respectively
(Fig. 4, in-house IVD). Two other correlations (gastric and intestinal
phase, respectively) compared the results from the second and third
inter-laboratory trials, applying the harmonized IVD method (Fig. 4,
harmonized IVD).
For each matrix, the average correlation and the standard deviation
were calculated. In addition, the matrix is shown in a color-coded pic-
ture, where red indicates high correlation, and green indicates low cor-
relation. Surprisingly, after the gastric phase, both correlations reached
similar values, 84 ± 6% for the in-house protocols and 79 ± 7% for the
harmonized method. This can be explained by a general lower degree
of hydrolysis in these samples, as observed on SDS-PAGE (Fig. 1) as
well as in lower numbers of peptides identified (Fig. 3, Supplemental
Data). However most importantly, after the intestinal phase of diges-
tion, the harmonized method generated a higher correlation of 64 ±
8% compared to the 48±16% obtainedwith in-house IVD. This observa-
tion allows the conclusion that the harmonized IVD indeed leads to a
clear improvement in result comparability at the end of the intestinal
phase.
For this analysis, in total six samples (total 29)were excluded due to
inconsistencies with the protocol or high discrepancies of their results
compared to the other laboratories. The following were reasons for
the exclusion of results. Laboratory 12 (1. trial, in-house IVD) was ex-
cluded from the calculation due to the lack of detectable proteins and
peptides by gel electrophoresis and mass spectrometry. Laboratory 1.2
(2. trial, harmonized IVD) was excluded because it did not respect the
IVD protocol (ratio of SMP compared to digestion juice). Laboratories
1.7 and 1.10 (2. trial, harmonized IVD) were excluded as outliers, dueFig. 5.Release of free amino acids after gastric and intestinal phases of IVD. HPLC analysis of sam
3 (b), after the gastric phase (light gray bars) and after the intestinal phase (dark graybars). SMP
amino acids present in the SMP. Average values (Av) with standard deviation (SD) are shown
responding digestion phase.to very low numbers of peptides after the gastric phase compared to
all other laboratories, laboratories 2.6 and 2.7 (3. trial, harmonized
IVD) were excluded due to very low casein hydrolysis, as observed by
gel electrophoresis (Fig. 1c, lanes 2.6 and 2.7 on the upper right gel).
3.5. Release of free amino acids during harmonized IVD
The degree of free amino acid release after the gastric and the intes-
tinal digestion phase of the harmonized IVD was analyzed by HPLC
(Bidlingmeyer et al., 1984) (Fig. 5). Overall, in the gastric phase, a very
small amount of free amino acids was released, consisting of 1% of the
total amino acids and was consistent between the second and third
trial applying the harmonizedmethod. In contrast, during the intestinal
phase, most of the proteins were hydrolyzed to amino acids and the re-
sults of the first trial applying the harmonized method were more het-
erogeneous than the final inter-laboratory trial. The high release of
free amino acids during the intestinal phase is consistent with the phys-
iological situation in the gastrointestinal tract, where the liberated
amino acids are absorbed mainly in the duodenal phase (Barbe et al.,
2014; Clemente, 2000). Moreover, the reduction in heterogeneity
could possibly be attributed to the better training of the participants
during a practical course and a more detailed protocol. Interestingly,
after the intestinal phase, the average total release of free amino acids
was 88% for the second trial (Fig. 5a) and 60% for the third (Fig. 5b),
both trials performedwith the harmonizedmethod. A possible explana-
tion for this difference, that was statistically insignificant, could be the
change in the procedure for stopping the IVD. For the second trial, a con-
centration of 1 mM Pefabloc® was recommended, while for the third
trial, this was increased to 5 mM due to the observation of incompleteples from both inter-laboratory trials applying the harmonized protocol, trial 2 (a) and trial
represents the free amino acids of undigested SMP, and SMP total is the theoretical value of
in logarithmic scale in mmol/kg of food, error bars are SD between all samples of the cor-
225L. Egger et al. / Food Research International 88 (2016) 217–225inhibition. This highlights the importance of stopping the reaction effec-
tively after sampling. The release of free amino acids, determined at the
third trial is in a close agreement (58%) with that recently measured
after gastric-duodenal digestion of SMP with a model closely related
to the harmonized IVD (Picariello et al., 2015).
3.6. Validation of IVD
The harmonized IVD method published by Minekus and coauthors
(Minekus et al., 2014) has been established based on physiologically
available and published in vivo enzyme and salt concentrations. Howev-
er, staticmodels are simplifiedmodels of a highly complex in vivo diges-
tion process. In particular, the status of hydrolysis during the gastric
phase is likely to differ from the in vivo situation, especially for solid
and semi-solid food matrices, keeping in mind that in vivo, the chyme
is dynamically processed and gradually released to the duodenum dur-
ing digestion rather than all at once and the pH is not fixed but gradually
decreases. Therefore, it is difficult to fully mimic the kinetic behavior of
the in vivo situation with a static model. The analyses presented in this
article confirm that the harmonized method improves the comparabili-
ty of IVD data and supports the advantages of this methodology as a ro-
bust and simple tool to study the digestive fate of oral intake. However,
true evaluation of digestive fate remains to be further investigated and
corroborated by in vivo trials. Therefore, a direct comparison between
results from IVD and in vivo would be a major step to validate the IVD
model.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.foodres.2015.12.006.
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